Browsing: Longevity Risk
Longevity and Mortality Investor’s coverage of bulk purchase annuity transactions. We are a leading source globally for longevity risk analysis, commentary and insights.
Lack of blockbuster deals but market remains busy as more schemes seek to de-risk.
Wealth factor affords life settlement cohort numerous options to enhance and extend life expectancy.
People with mental health conditions often suffer from worse physical health, have more age-related diseases, and have a lower average life expectancy than people without a mental illness.
The temptation for schemes to reach blindly for the ‘quick and easy’ option is high, particularly for smaller schemes. This could result in requests for contributions from sponsors that are not strictly required, and lower returning investment strategies being implemented.
Life Risk News Q&A: Perry Koons, Director of Capital Markets at life settlement provider Maple Life Financial, offers his thoughts on the state of the life settlement market at the halfway point of 2025.
At the end of June, the Continuous Mortality Investigation in the UK, which produces mortality data and analysis, issued its latest update, CMI_2024, which showed an increase in cohort life expectancies at age 65 in England and Wales.
The deal, worth $800m, secures the retirement benefits of over 1,700 retirees and over 3,000 deferred members.
In total, the transactions insure the benefits of 1,127 pensioners and dependants as well as 1,365 deferred members,
Chariot Re will reinsure approximately $10bn of liabilities, including structured settlement annuity contracts and group annuity contracts associated with pension risk transfers originated by MetLife.
New report says that Bermuda accounted for over 60% of reserves ceded for L/A transactions effective in 2023 and 2024.